Close menu




Comments

Photo credits: pixabay.com

Commented by André Will-Laudien on October 22nd, 2025 | 07:35 CEST

Gold and silver – New record highs! Keep an eye on Barrick, Agnico Eagle, Desert Gold, and First Majestic!

  • Mining
  • Gold
  • Silver
  • Commodities

Silver prices broke through the USD 53 mark for the first time at the beginning of the week, and gold is attempting to reach the USD 4,300 mark. Precious metal enthusiasts have been anticipating these moves for a long time, but traders on the futures exchanges clearly have not. In addition to extreme physical scarcity, the exploding prices are also attributed to heavy short squeezes. The physical silver market is under tremendous pressure as the availability of real metal to hedge the numerous futures transactions is severely limited. This imbalance is causing erratic market reactions and driving the spot price into an almost exponential sell-off. The current rally in precious metals is driven by geopolitical uncertainty, industrial demand factors, and the search for safe investments. In times of excessive government debt, the weakness of the US dollar is now also weighing on the market. Which companies should investors keep a close eye on now?

Read

Commented by Fabian Lorenz on October 22nd, 2025 | 07:30 CEST

SHARE PRICE EXPLOSION for commodity gems!? Nordex, Aurubis, Salzgitter, and Power Metallic Mines!

  • Mining
  • Lithium
  • Copper
  • Commodities
  • Steel
  • Wind
  • renewableenergies

Shares in the commodities and precious metals sector have been unstoppable in recent weeks. Power Metallic Mines could soon become an explosive latecomer to the rally. There are good reasons for this, as the CEO recently made clear. At Aurubis, the rally appears to be over for now. Analysts are skeptical, and the major shareholder is cashing in his shares - albeit in an unusual way. So should you sell now, too? The past few months have been unusually positive for Nordex. There is currently no sign of a slump in the wind business. What are analysts saying after the latest order intake?

Read

Commented by Carsten Mainitz on October 22nd, 2025 | 07:25 CEST

The stock market success stories Almonty Industries, TKMS, and Steyr Motors are opening a new chapter - and it is still not too late to get in!

  • Mining
  • Tungsten
  • CriticalMetals
  • Automotive
  • hightech
  • Defense

The trade conflict between the US and China is intensifying and reaching a new strategic dimension. Beijing is deliberately restricting exports of critical raw materials and rare earths that are indispensable for high-tech industries, defense, and the energy transition. Western industries are coming under pressure, security of supply is faltering, and prices are rising. Meanwhile, the beneficiaries of this situation, such as producers of critical raw materials, are experiencing a boom. What happens next, and what does the stock market newcomer TKMS have to do with it?

Read

Commented by Nico Popp on October 22nd, 2025 | 07:20 CEST

Dividend stocks with that certain something: RE Royalties, freenet, Porsche

  • royalties
  • dividends
  • Telecommunications
  • Automotive

Recent media reports of an impending banking crisis in the US have increased market volatility. US President Trump's erratic policies are not exactly helping to calm the markets either. In times like these, some investors are looking for safe havens for their portfolios. For many investors, dividend stocks are the primary choice for this purpose, alongside bonds. We highlight some interesting picks, including RE Royalties, which stands out with a business model that scores points with its unique selling points.

Read

Commented by Fabian Lorenz on October 22nd, 2025 | 07:15 CEST

HYDROGEN IS ALIVE! Bloom Energy, thyssenkrupp nucera, and dynaCERT! 1,000% not enough?

  • Hydrogen
  • greenhydrogen
  • cleantech
  • renewableenergies

Plug Power has gained nearly 500% since May, proving that hydrogen is very much alive. The applications may be different from what was expected in the hype a few years ago - more specific and niche-focused. Investors are speculating that hydrogen will benefit from the energy boom driven by artificial intelligence. The same applies to Bloom Energy, whose stock has exploded by 1,000% over the past year. dynaCERT is active in an exciting niche, offering conversion kits for diesel engines ranging from trucks to container ships. Initial sales successes give hope for more. Will emission certificates follow? And what is Germany's hydrogen hope, thyssenkrupp nucera, doing? It remains in the shadow of TKMS. Still, one analyst sees upside potential of around 50%.

Read

Commented by Nico Popp on October 22nd, 2025 | 07:10 CEST

Hype and day-to-day business – What matters now: European Lithium, BMW, Mercedes-Benz

  • Mining
  • Lithium
  • CriticalMetals
  • Electromobility
  • RareEarths

European Lithium shares have recently caused quite a stir. But what is behind the surge that has multiplied its value within just a few days? What role does the Company actually play - for the US and also for Europe? We sort through the many reports on European Lithium and show where the Company could be headed in the medium term. One thing seems certain: Without European Lithium, the outlook for the automotive industry on both sides of the Atlantic looks bleak. Reason enough to take a closer look at the background.

Read

Commented by Armin Schulz on October 22nd, 2025 | 07:05 CEST

Bitcoin soars: How Strategy, Nakiki, and BlackRock are benefiting from the new MiCA regulation on tokenization

  • Bitcoin
  • Tokenization
  • crypto
  • Digitization
  • Technology

Bitcoin is reaching new record highs. The hashrate is exploding, and analysts are predicting prices of USD 250,000. At the same time, the EU is establishing clear rules for tokenization through MiCA. This unique combination of technological strength and regulatory clarity is unleashing unprecedented institutional interest. Three companies are strategically positioned to capitalize on this boom: Strategy, Nakiki, and BlackRock. Here, we take a closer look at how these companies have positioned themselves.

Read

Commented by Nico Popp on October 22nd, 2025 | 07:00 CEST

Important piece of the puzzle in the fight against cancer: Vidac Pharma, Roche, Merck & Co.

  • Biotechnology
  • Biotech
  • Pharma
  • Cancer
  • Technology
  • Innovations

The pharmaceutical market is enormous - and continues to grow. Market research institute Evaluate forecasts an increase to around USD 1.7 trillion by 2030, representing an annual growth rate of 7.7%. Oncology promises the highest sales, at around USD 300 billion. However, there is no single approach. Instead, new modalities and technologies such as antibody-drug conjugates (ADCs), cell and gene therapies, and radiopharmaceuticals are transforming the industry and gaining significant traction. One thing is clear: progress in the biotech sector is increasingly achieved through the combination of active ingredients and technologies. What role does the biotech company Vidac Pharma play in this?

Read

Commented by André Will-Laudien on October 22nd, 2025 | 06:55 CEST

NEO Battery Materials – Batteries as the key to technological sovereignty

  • BatteryMetals
  • Batteries
  • Technology

The situation sounds challenging! The global energy transition and the rise of autonomous systems are driving demand for high-performance batteries to historic highs. However, the dependence of Western industries on Chinese supply chains remains a geopolitical risk factor of the first order. In this tense environment, NEO Battery Materials Ltd. (NBM) is positioning itself as North America's hope for the development of cost-efficient, silicon-enhanced lithium-ion batteries. One of the newcomer's great strengths is its combination of modern and efficient materials science, cell architecture, and process optimization into an integrated solution. The focus is on establishing an independent value chain in North America. Time is of the essence, and the barrier to entry is high! Why are investors and producers lining up now?

Read

Commented by André Will-Laudien on October 21st, 2025 | 07:45 CEST

AI boom and DAX fireworks! Another 100% with NetraMark, Bayer, and Novo Nordisk

  • AI
  • Biotechnology
  • Biotech
  • Pharma

Savvy investors are already taking notice! Artificial intelligence is revolutionizing drug research and radically reducing development costs. Algorithms are discovering molecular patterns that even the most experienced researchers would overlook, thus accelerating the path from laboratory to patient. Whether in oncology, rare diseases, or metabolic disorders, big data-driven models now enable more precise drug predictions and more realistic simulations of clinical outcomes. Those who understand AI can profit handsomely from the next biotech boom. You just have to muster the courage to finally get involved!

Read